SEC Form 4 · accession 0001596783-17-000178
Catalent, Inc. · CTLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry Littlejohns
Officer — President, Biologics & SDD
Period of report
Dec 11, 2017
Accepted (ET)
Dec 12, 2017 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596783
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase Common StockF2 | $18.57 | Dec 11, 2017 | A | 1,176 | A | — | Dec 11, 2022 | Common Stock | 1,176 | 28,968 | D |
Explanation of responses
- F1Due to the satisfaction of performance criteria, the reporting person was issued vested and exercisable options to purchase shares of common stock of the Issuer.
- F2On December 11, 2012, the reporting person was granted options to purchase common stock of the Issuer, which options began to vest and become exercisable upon the passage of time and, in certain cases, the satisfaction of performance criteria geginning December 11, 2013. All options have vested or have been cancelled as of the date of this Form.